CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD

/Home/Lyophilization and Protein Formulation Patents/Patent Articles - Lyophilization/European Patents - Lyophilization

Patent number: WO2005041937
Publication date: 2005-05-12
Inventor: KOSTANSKI JANUSZ W (US); MATSUDA TAKAKUNI (JP); NERURKAR MANOJ (US); NARINGREKAR VIJAY H (US)
Applicant: OTSUKA PHARMA CO LTD (JP);; KOSTANSKI JANUSZ W (US);; MATSUDA TAKAKUNI (JP);; NERURKAR MANOJ (US);; NARINGREKAR VIJAY H (US)
Classification:
- international: A61K9/19; A61K47/38; A61K47/26
- european:
Application number: WO2004US34367 20041018
Priority number(s): US20030513618P 20031023
Abstract of WO2005041937

A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided.
Data supplied from the esp@cenet database - Worldwi